Jeffrey Baumgartner - 03 Jun 2025 Form 4 Insider Report for CIRRUS LOGIC, INC. (CRUS)

Role
EVP, R&D
Signature
By: Gregory Scott Thomas attorney-in-fact For: Jeffrey Baumgartner
Issuer symbol
CRUS
Transactions as of
03 Jun 2025
Transactions value $
-$616,600
Form type
4
Filing time
05 Jun 2025, 16:31:40 UTC
Previous filing
04 Mar 2025
Next filing
03 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Baumgartner Jeffrey W EVP, R&D 800 WEST 6TH STREET, AUSTIN By: Gregory Scott Thomas attorney-in-fact For: Jeffrey Baumgartner 05 Jun 2025 0001777830

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRUS Common Stock Options Exercise $383K +10K +71.42% $38.34 24K 03 Jun 2025 Direct F1
transaction CRUS Common Stock Sale -$1M -10K -41.66% $100.00 14K 03 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRUS Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -36.51% $0.00 17.4K 03 Jun 2025 Common Stock 10K $38.34 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2024.
F2 Only vested shares can be exercised under this option. 25% of the shares vested on 05/02/19; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 05/02/22.